Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maruša Turk"'
Publikováno v:
Cancer Research. 81:227-227
Introduction: Treatment resistance contributes importantly to clinical response of metastatic prostate cancer (mPC) patients. We hypothesize that patients with more resistant lesions would lead to more unfavorable treatment response. The goal of this
Autor:
Martina Vrankar, Damijan Valentinuzzi, Matea Maruna, Maruša Turk, Maja Cemazar, Robert Jeraj, Urban Simoncic, Gregor Sersa, Katja Ursic
Publikováno v:
Cancer Immunology Research. 8:A09-A09
Immune checkpoint inhibitors have shown impressive benefits for patients with various types of cancer. However, patients who respond are still a minority. To improve the response rates, combinations of various immunotherapies, as well as combinations
Publikováno v:
Physics in Medicine & Biology. 64:115001
Metastatic cancer patients invariably develop treatment resistance. Different levels of resistance lead to observed heterogeneity in treatment response. The main goal was to evaluate treatment response heterogeneity with a computation model simulatin
Publikováno v:
Physics in Medicine & Biology. 64:025017
Cancer immunotherapy is a rapidly developing field, with numerous drugs and therapy combinations waiting to be tested in pre-clinical and clinical settings. However, the costly and time-consuming trial-and-error approach to development of new treatme
Publikováno v:
Physics in Medicine & Biology; Jun2019, Vol. 64 Issue 11, p1-1, 1p